ShiftPixy, Inc.

2023 Q2 Form 10-Q Financial Statement

#000162828023011665 Filed on April 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $144.0K $818.0K
YoY Change 105.71% -75.57%
Cash & Equivalents $144.0K $818.0K
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $527.0K $293.0K
YoY Change 454.74% 121.97%
Inventory
Prepaid Expenses $256.0K $198.0K
Receivables $2.583M $745.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.254M $4.226M
YoY Change -31.77% -45.66%
LONG-TERM ASSETS
Property, Plant & Equipment $6.232M $2.769M
YoY Change 115.04% -7.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.098M $1.019M
YoY Change 16.31% 7.94%
Total Long-Term Assets $7.330M $7.555M
YoY Change -94.31% -94.29%
TOTAL ASSETS
Total Short-Term Assets $3.254M $4.226M
Total Long-Term Assets $7.330M $7.555M
Total Assets $10.58M $11.78M
YoY Change -92.08% -91.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.49M $16.55M
YoY Change 51.75% 72.03%
Accrued Expenses $25.66M $21.37M
YoY Change 69.67% 81.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.91M $39.54M
YoY Change 60.98% 74.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.072M $7.960M
YoY Change -34.66% -29.68%
Total Long-Term Liabilities $8.072M $7.960M
YoY Change -34.66% -29.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.91M $39.54M
Total Long-Term Liabilities $8.072M $7.960M
Total Liabilities $52.98M $47.50M
YoY Change 31.63% 39.71%
SHAREHOLDERS EQUITY
Retained Earnings -$211.4M -$203.9M
YoY Change 17.56% 22.17%
Common Stock $6.000K $6.000K
YoY Change 50.0% 100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$42.40M -$35.72M
YoY Change
Total Liabilities & Shareholders Equity $10.58M $11.78M
YoY Change -92.08% -91.58%

Cashflow Statement

Concept 2023 Q2 2023 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Central Index Key
EntityCentralIndexKey
0001675634
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2022Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-02-28
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37954
dei Entity Registrant Name
EntityRegistrantName
SHIFTPIXY, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4211438
dei Entity Address Address Line1
EntityAddressAddressLine1
13450 W Sunrise Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
dei Entity Address City Or Town
EntityAddressCityOrTown
Sunrise
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33323
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
798-9100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
PIXY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10055515 shares
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
818000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
745000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
279000 usd
CY2023Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2172000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2105000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
198000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
696000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
293000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
187000 usd
CY2023Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
0 usd
CY2022Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
116969000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4226000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
120854000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2769000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2769000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3767000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4076000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1019000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
919000 usd
CY2023Q1 us-gaap Assets
Assets
11781000 usd
CY2022Q3 us-gaap Assets
Assets
128618000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
16546000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
17122000 usd
CY2023Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
20926000 usd
CY2022Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
16055000 usd
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
439000 usd
CY2022Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
567000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1628000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1362000 usd
CY2023Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
0 shares
CY2022Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
11500000 shares
CY2023Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
0 usd
CY2022Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
116969000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
39539000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
152075000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3237000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3541000 usd
CY2023Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
913000 usd
CY2022Q3 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
1227000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
3810000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
3269000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
47499000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
160112000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8600000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8600000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9976536 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
513349 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
168193000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
151731000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-203917000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-192725000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-35718000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-40988000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
0 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
9494000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-35718000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31494000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11781000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128618000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4579000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10437000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9844000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19378000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
4095000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
10498000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
8941000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
18743000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
484000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
-61000 usd
us-gaap Gross Profit
GrossProfit
903000 usd
us-gaap Gross Profit
GrossProfit
635000 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
2598000 usd
CY2022Q1 us-gaap Salaries And Wages
SalariesAndWages
3653000 usd
us-gaap Salaries And Wages
SalariesAndWages
4857000 usd
us-gaap Salaries And Wages
SalariesAndWages
7543000 usd
CY2023Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
7000 usd
CY2022Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
28000 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
17000 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
56000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
870000 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
1677000 usd
us-gaap Professional Fees
ProfessionalFees
2065000 usd
us-gaap Professional Fees
ProfessionalFees
3414000 usd
CY2023Q1 pixy Software Development
SoftwareDevelopment
119000 usd
CY2022Q1 pixy Software Development
SoftwareDevelopment
1073000 usd
pixy Software Development
SoftwareDevelopment
179000 usd
pixy Software Development
SoftwareDevelopment
2234000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
150000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
130000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
299000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
253000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1765000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2354000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3516000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4693000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
5509000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
8915000 usd
us-gaap Operating Expenses
OperatingExpenses
10933000 usd
us-gaap Operating Expenses
OperatingExpenses
18193000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5025000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8976000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10030000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17558000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
239000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1000 usd
us-gaap Interest Expense
InterestExpense
457000 usd
us-gaap Interest Expense
InterestExpense
2000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
642000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
13000 usd
us-gaap Other Income
OtherIncome
642000 usd
us-gaap Other Income
OtherIncome
16000 usd
CY2023Q1 pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
0 usd
CY2022Q1 pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
515000 usd
pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
0 usd
pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
515000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
403000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-503000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
185000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-501000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4622000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-9479000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-9845000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-18059000 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-607000 usd
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-18000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-807000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-151000 usd
CY2023Q1 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-540000 usd
CY2022Q1 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-540000 usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5769000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9497000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11192000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18210000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
127145000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2023Q1 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
0 usd
CY2022Q1 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
-7731000 usd
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
0 usd
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
-7731000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5769000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17228000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-138337000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25941000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.53
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.53
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-55.13
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-55.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-14.29
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-14.29
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-76.77
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-76.77
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.06
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.06
CY2022Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.06
CY2022Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.06
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.08
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.08
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.45
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.45
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-55.19
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-55.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-77.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-77.22
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9703645 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9703645 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
312155 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
312155 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9625660 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9625660 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335934 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335934 shares
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31494000 usd
us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
127145000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
127145000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
500000 usd
pixy Adjustments To Additional Paid In Capital Modification Of Warrants
AdjustmentsToAdditionalPaidInCapitalModificationOfWarrants
106000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1434000 usd
pixy Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
540000 usd
us-gaap Profit Loss
ProfitLoss
-11192000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-35718000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-32168000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
245000 usd
CY2023Q1 pixy Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
540000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5769000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-35718000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40923000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6861000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
747000 usd
pixy Remeasurement Of Temporary Equity
RemeasurementOfTemporaryEquity
13270000 usd
pixy Withdrawal From Spacs1 Forms
WithdrawalFromSPACS1Forms
37978000 usd
us-gaap Profit Loss
ProfitLoss
-18210000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10727000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30392000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
339000 usd
CY2022Q1 pixy Withdrawal From Spacs1 Forms
WithdrawalFromSPACS1Forms
37978000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9497000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10727000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11192000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18210000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-807000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-151000 usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-540000 usd
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-9845000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-18059000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
299000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
253000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
500000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
747000 usd
pixy Warrant Modification Noncash Expense
WarrantModificationNoncashExpense
106000 usd
pixy Warrant Modification Noncash Expense
WarrantModificationNoncashExpense
0 usd
pixy Share Based Payment Arrangement Noncash Expense Directors
ShareBasedPaymentArrangementNoncashExpenseDirectors
113000 usd
pixy Share Based Payment Arrangement Noncash Expense Directors
ShareBasedPaymentArrangementNoncashExpenseDirectors
0 usd
pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
0 usd
pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
515000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
85000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
217000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
466000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-117000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
67000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-126000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-392000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
573000 usd
pixy Deposits Workers Compensation
DepositsWorkersCompensation
0 usd
pixy Deposits Workers Compensation
DepositsWorkersCompensation
414000 usd
pixy Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
0 usd
pixy Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
100000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-769000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3065000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4871000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3297000 usd
pixy Increase Decrease In Accrued Workers Compensation
IncreaseDecreaseInAccruedWorkersCompensation
-442000 usd
pixy Increase Decrease In Accrued Workers Compensation
IncreaseDecreaseInAccruedWorkersCompensation
-452000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
4522000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
7726000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5323000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10333000 usd
pixy Net Cash Provided By Used In Operating Activities Noncontrolling Interest
NetCashProvidedByUsedInOperatingActivitiesNoncontrollingInterest
0 usd
pixy Net Cash Provided By Used In Operating Activities Noncontrolling Interest
NetCashProvidedByUsedInOperatingActivitiesNoncontrollingInterest
0 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5323000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10333000 usd
pixy Payments For Investment Of Initial Public Offering Proceeds
PaymentsForInvestmentOfInitialPublicOfferingProceeds
0 usd
pixy Payments For Investment Of Initial Public Offering Proceeds
PaymentsForInvestmentOfInitialPublicOfferingProceeds
116732000 usd
pixy Redeemable Noncontrolling Interest Equity Common Redemption Funds Distributed To Shareholders
RedeemableNoncontrollingInterestEquityCommonRedemptionFundsDistributedToShareholders
117574000 usd
pixy Redeemable Noncontrolling Interest Equity Common Redemption Funds Distributed To Shareholders
RedeemableNoncontrollingInterestEquityCommonRedemptionFundsDistributedToShareholders
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
299000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
461000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
117275000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-117193000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3502000 usd
pixy Proceeds From Variable Interest Entity Initial Public Offering
ProceedsFromVariableInterestEntityInitialPublicOffering
0 usd
pixy Proceeds From Variable Interest Entity Initial Public Offering
ProceedsFromVariableInterestEntityInitialPublicOffering
116725000 usd
pixy Payments To Variable Interest Entity Shareholders
PaymentsToVariableInterestEntityShareholders
117574000 usd
pixy Payments To Variable Interest Entity Shareholders
PaymentsToVariableInterestEntityShareholders
0 usd
pixy Proceeds From Warrant Exercises Net Of Offering Costs
ProceedsFromWarrantExercisesNetOfOfferingCosts
1000 usd
pixy Proceeds From Warrant Exercises Net Of Offering Costs
ProceedsFromWarrantExercisesNetOfOfferingCosts
5409000 usd
pixy Proceeds From Issuance Of Private Placement Net Of Offering Costs
ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
4387000 usd
pixy Proceeds From Issuance Of Private Placement Net Of Offering Costs
ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
4183000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-111752000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
129676000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
200000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2150000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1199000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
818000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3349000 usd
us-gaap Interest Paid Net
InterestPaidNet
102000 usd
us-gaap Interest Paid Net
InterestPaidNet
2000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
pixy Deconsolidation Of Variable Interest Entity
DeconsolidationOfVariableInterestEntity
9494000 usd
pixy Deconsolidation Of Variable Interest Entity
DeconsolidationOfVariableInterestEntity
0 usd
pixy Deferred Offering Costs Special Purpose Acquisition Companies
DeferredOfferingCostsSpecialPurposeAcquisitionCompanies
0 usd
pixy Deferred Offering Costs Special Purpose Acquisition Companies
DeferredOfferingCostsSpecialPurposeAcquisitionCompanies
37978000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
13728000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7687000 usd
pixy Increase In Marketable Securities In Trust Account And Class A Mandatory Redeemable Common Shares
IncreaseInMarketableSecuritiesInTrustAccountAndClassAMandatoryRedeemableCommonShares
801000 usd
pixy Increase In Marketable Securities In Trust Account And Class A Mandatory Redeemable Common Shares
IncreaseInMarketableSecuritiesInTrustAccountAndClassAMandatoryRedeemableCommonShares
0 usd
pixy Transfer Of Preferred Shares To Common Shares
TransferOfPreferredSharesToCommonShares
1000 usd
pixy Transfer Of Preferred Shares To Common Shares
TransferOfPreferredSharesToCommonShares
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskThe Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal.
CY2023Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1000000 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumption as a going concern; management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Liability for legal contingencies</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Useful lives of property and equipment</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deferred income taxes and related valuation allowance</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Valuation of illiquid non-controlling interest in SPAC shares transferred and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Projected development of workers’ compensation claims.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions are difficult to measure of value. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.</span></div>
CY2023Q1 us-gaap Cash
Cash
800000 usd
CY2023Q1 pixy Working Capital Deficit
WorkingCapitalDeficit
35300000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5300000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-203900000 usd
pixy Contract With Customer Term
ContractWithCustomerTerm
P12M
pixy Contract With Customer Cancellation Period
ContractWithCustomerCancellationPeriod
P30D
CY2023Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2200000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2100000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4579000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10437000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9844000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19378000 usd
CY2023Q1 pixy Gross Billings
GrossBillings
12000000 usd
pixy Gross Billings
GrossBillings
23600000 usd
CY2023Q1 pixy Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
10400000 usd
pixy Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
20600000 usd
CY2022Q1 pixy Gross Billings
GrossBillings
12600000 usd
pixy Gross Billings
GrossBillings
25500000 usd
CY2022Q1 pixy Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
11000000 usd
pixy Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
22200000 usd
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
288832 shares
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2023Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1100000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2200000 usd
CY2023Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2022Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1359362 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
242097 shares
CY2023Q1 pixy Workers Compensation Claim Responsibility Per Occurrence
WorkersCompensationClaimResponsibilityPerOccurrence
500000 usd
CY2022Q3 pixy Workers Compensation Asset Noncurrent
WorkersCompensationAssetNoncurrent
0 usd
CY2023Q1 pixy Workers Compensation Asset Noncurrent
WorkersCompensationAssetNoncurrent
0 usd
CY2023Q1 pixy Workers Compensation Asset Current
WorkersCompensationAssetCurrent
0 usd
CY2022Q3 pixy Workers Compensation Asset Current
WorkersCompensationAssetCurrent
0 usd
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
400000 usd
CY2022Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
600000 usd
CY2023Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
900000 usd
CY2022Q3 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
1200000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1600000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1400000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
3800000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
3300000 usd
CY2022Q3 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Noncurrent
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetNoncurrent
0 usd
CY2023Q1 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Noncurrent
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetNoncurrent
0 usd
CY2023Q1 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Current
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetCurrent
0 usd
CY2022Q3 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Current
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetCurrent
0 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
500000 usd
us-gaap Advertising Expense
AdvertisingExpense
900000 usd
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
400000 usd
us-gaap Advertising Expense
AdvertisingExpense
900000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1359362 shares
CY2023Q1 pixy Share Based Compensation Arrangement By Share Based Payment Award Number Of Stock Based Compensation Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfStockBasedCompensationPlans
1 plan
CY2022Q4 pixy Other Commitments Number Of Special Purpose Acquisition Company Sponsorships
OtherCommitmentsNumberOfSpecialPurposeAcquisitionCompanySponsorships
1 sponsorship
CY2021Q2 pixy Other Commitments Number Of Special Purpose Acquisition Company Sponsorships
OtherCommitmentsNumberOfSpecialPurposeAcquisitionCompanySponsorships
4 sponsorship
CY2023Q1 pixy Other Commitments Number Of Special Purpose Acquisition Company Sponsorships
OtherCommitmentsNumberOfSpecialPurposeAcquisitionCompanySponsorships
0 sponsorship
CY2021Q4 pixy Variable Interest Entity Qualitative Or Quantitative Information Common Stock Shares Transferred
VariableInterestEntityQualitativeOrQuantitativeInformationCommonStockSharesTransferred
15000 shares
CY2022 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4000000 usd
us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4004000 usd
CY2022 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4004000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
116700000 usd
CY2021Q2 pixy Other Commitments Percentage Of Outstanding Shares Per Acquisition Company
OtherCommitmentsPercentageOfOutstandingSharesPerAcquisitionCompany
0.15
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1 shares
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
127100000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
522786 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P7Y2M12D
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
47.99
pixy Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
854166 shares
pixy Class Of Warrant Or Right Weighted Average Remaining Life Issued
ClassOfWarrantOrRightWeightedAverageRemainingLifeIssued
P7Y1M6D
pixy Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
12.00
pixy Class Of Warrant Or Right Shares Exercised
ClassOfWarrantOrRightSharesExercised
124203 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1252749 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P6Y7M6D
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
33.61
CY2023Q1 pixy Class Of Warrant Or Right Shares Exercisable
ClassOfWarrantOrRightSharesExercisable
398582 shares
pixy Weighted Remaining Life Years Exercisable
WeightedRemainingLifeYearsExercisable
P6Y9M18D
CY2023Q1 pixy Weighted Average Exercise Price Exercisable
WeightedAverageExercisePriceExercisable
86.38
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2500 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
30000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
30000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
749997 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11753 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11753 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
733.00
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
733.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1750 shares
pixy Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageRemainingContractualTerm
P8Y3M18D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.70
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10003 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10003 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
813.70
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
813.70
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1153000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5269 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1146
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1560 shares
pixy Weighted Average Remaining Contractual Life In Years Vested
WeightedAverageRemainingContractualLifeInYearsVested
P7Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
434.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
716 shares
pixy Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageRemainingContractualTerm
P8Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
293.00
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6113 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y4M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1064
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
10003 shares
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
10003 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
814
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
814
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6113 shares
pixy Share Based Payment Arrangement Option Exercise Price Range Vested Weighted Average Remaining Contractual Term
ShareBasedPaymentArrangementOptionExercisePriceRangeVestedWeightedAverageRemainingContractualTerm
P7Y4M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1064
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3900000 usd
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
3800000 usd
CY2023Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
3800000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
307792 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
563753 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1039000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1073000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1032000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
746000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
488000 usd
CY2023Q1 pixy Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
256000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4634000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
563000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4071000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P63M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554
CY2021Q2 pixy Other Commitments Number Of Special Purpose Acquisition Company Sponsorships
OtherCommitmentsNumberOfSpecialPurposeAcquisitionCompanySponsorships
4 sponsorship
CY2023Q1 pixy Other Commitments Outstanding Uncollectible Loans
OtherCommitmentsOutstandingUncollectibleLoans
700000 usd

Files In Submission

Name View Source Status
0001628280-23-011665-index-headers.html Edgar Link pending
0001628280-23-011665-index.html Edgar Link pending
0001628280-23-011665.txt Edgar Link pending
0001628280-23-011665-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pixy-20230228.htm Edgar Link pending
pixy-20230228.xsd Edgar Link pending
pixy-20230228xexx311.htm Edgar Link pending
pixy-20230228xexx312.htm Edgar Link pending
pixy-20230228xexx321.htm Edgar Link pending
pixy-20230228xexx322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
pixy-20230228_cal.xml Edgar Link unprocessable
pixy-20230228_lab.xml Edgar Link unprocessable
pixy-20230228_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pixy-20230228_def.xml Edgar Link unprocessable
pixy-20230228_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending